News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hamill John
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/12/2015 |
4
| Hamill John (CFO) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 136,381 shares
@ $0 |
|
| 05/04/2015 |
4
| Hamill John (CFO) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 15,000 options to buy
@ $7.31, valued at
$109.7k
|
|
| 12/15/2014 |
4
| Hamill John (CFO) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 45,000 options to buy
@ $4.67, valued at
$210.2k
|
|
| 08/15/2014 |
4
| Hamill John (CFO) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 24,000 options to buy
@ $4.49, valued at
$107.8k
|
|
| 05/16/2014 |
4
| Hamill John (CFO) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 30,769 options to buy
@ $11.9, valued at
$366.2k
|
|
| 10/17/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2013 |
4
| Hamill John (SVP, CFO) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Granted 110,000 options to buy
@ $0.94, valued at
$103.4k
|
|
| 09/26/2012 |
4
| Hamill John (SVP, CFO) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Granted 100,000 shares
@ $2.92, valued at
$292k
Granted 250,000 options to buy
@ $2.92, valued at
$730k
|
|
| 09/26/2012 |
3
| Hamill John (SVP, CFO) has filed a Form 3 on SAVIENT PHARMACEUTICALS INC |
|
|